Autologous splenocyte reinfusion improves antibody-mediated immune response to the 23-valent pneumococcal polysaccharide-based vaccine in splenectomized mice

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Common clinical options, currently, for necessary splenectomy are vaccinations and antibiotic prophylaxis. However, despite these two adjuncts, there still occur numerous cases of overwhelming post-splenectomy infection. To examine whether reperfusion of critical splenic lymphocytes could boost immune response, we harvested splenic lymphocytes, reperfused the autologous lymphocytes, and then administered a pneumococcal vaccine (PNEUMOVAX® 23, i.e., PPSV23) in splenectomized mice. We found that splenectomy impaired the immune response in the splenectomized group compared to the non-splenectomized group; the splenectomized group with lymphocyte reinfusion had a higher response to polysaccharide vaccination based on antibody titer than the splenectomized group without lymphocyte reinfusion. The sham group with the native spleen had the most elevated antibody titer against the PPSV23 polysaccharide antigen. This may be additive, resulting from contributions of the splenic structure, along with the phagocytic function of the spleen and its constituent cells affecting the antibody response. Reinfusion of splenic lymphocytes may enhance immunity without the complications associated with splenic fragment autotransplantation, which never gained acceptance. This technique is safe and simple since the splenic lymphocytes are autologous and, therefore, not self-reactive, and very similar to autologous blood transfusion. This concept may be beneficial in cases of unavoidable splenectomy, especially in pediatric cases.

References Powered by Scopus

Overview of the immune response

1405Citations
N/AReaders
Get full text

Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.

810Citations
N/AReaders
Get full text

Polyvalent Pneumococcal-Polysaccharide Immunization of Patients with Sickle-Cell Anemia and Patients with Splenectomy

320Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Piezo1-mediated mechanosensation in bone marrow macrophages promotes vascular niche regeneration after irradiation injury

33Citations
N/AReaders
Get full text

Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis

24Citations
N/AReaders
Get full text

Vaccine coverage for recommended vaccines among splenectomised patients in Apulia, South Italy: A retrospective cohort study

5Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, S. C., & Kabeer, M. H. (2020). Autologous splenocyte reinfusion improves antibody-mediated immune response to the 23-valent pneumococcal polysaccharide-based vaccine in splenectomized mice. Biomolecules, 10(5). https://doi.org/10.3390/biom10050704

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Professor / Associate Prof. 1

20%

Lecturer / Post doc 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

60%

Nursing and Health Professions 2

40%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 15

Save time finding and organizing research with Mendeley

Sign up for free